Authors:M. Javed, I. Khan, M. Naeem, S. Asghar, H. Naseer, M. Iqbal, and J. Anwar
A tetradentate set of N2O2 salicylaldehyde-amine-N-dione Schiff base was prepared by condensation with salicylaldehyde, ethylenediamine, 2,4-dione and
reduction with NaBH4. The ligand system was characterized by 1H-NMR and FT-IR spectroscopy and HPLC. Radiolabeling studies of the 99mTc-complex were performed using stannous ions as the reducing agent. The purity of the complex was determined by ascending
solvent system on paper chromatography and instant thin-layer chromatography (ITLC). The yield of the complex was >90%. Biodistribution
of the 99mTc-complex of the precursor was studied in rabbits. A significant uptake and retention of injected activity was observed in
the liver and cleared through the bladder. A faint activity was also observed in kidneys. These results indicate that the
proposed system may be suitable for development of a liver/spleen imaging agent for future clinical applications.